Citigroup Cuts Bath & Body Works (NYSE:BBWI) Price Target to $40.00

Bath & Body Works (NYSE:BBWI) had its target price reduced by Citigroup from $42.00 to $40.00 in a report issued on Tuesday,Benzinga reports. Citigroup currently has a buy rating on the stock.

BBWI has been the topic of several other research reports. Barclays lowered their target price on shares of Bath & Body Works from $35.00 to $30.00 and set an “equal weight” rating on the stock in a research note on Friday, May 30th. The Goldman Sachs Group reduced their price target on Bath & Body Works from $44.00 to $43.00 and set a “buy” rating on the stock in a report on Friday, May 30th. Morgan Stanley reduced their price target on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a report on Tuesday, May 6th. UBS Group lifted their price target on Bath & Body Works from $32.00 to $36.00 and gave the stock a “neutral” rating in a report on Tuesday, May 20th. Finally, Wells Fargo & Company lifted their price target on Bath & Body Works from $40.00 to $44.00 and gave the stock an “overweight” rating in a report on Wednesday, May 14th. Fourteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $42.06.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $29.4010 on Tuesday. The company’s fifty day moving average price is $30.19 and its 200 day moving average price is $31.08. Bath & Body Works has a 1 year low of $24.94 and a 1 year high of $41.87. The stock has a market capitalization of $6.22 billion, a P/E ratio of 7.84, a P/E/G ratio of 0.99 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.42 billion. During the same quarter last year, the company earned $0.38 EPS. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. Sell-side analysts predict that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be given a dividend of $0.20 per share. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.7%. Bath & Body Works’s dividend payout ratio is currently 21.33%.

Institutional Investors Weigh In On Bath & Body Works

A number of large investors have recently modified their holdings of the business. Marex Group plc purchased a new stake in shares of Bath & Body Works during the second quarter worth $745,000. State of Wyoming grew its holdings in shares of Bath & Body Works by 6.2% during the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after buying an additional 661 shares in the last quarter. Headlands Technologies LLC grew its holdings in shares of Bath & Body Works by 189.7% during the second quarter. Headlands Technologies LLC now owns 22,369 shares of the company’s stock worth $670,000 after buying an additional 14,648 shares in the last quarter. Corient Private Wealth LLC grew its holdings in shares of Bath & Body Works by 10.8% during the second quarter. Corient Private Wealth LLC now owns 20,276 shares of the company’s stock worth $607,000 after buying an additional 1,977 shares in the last quarter. Finally, Captrust Financial Advisors grew its holdings in shares of Bath & Body Works by 14.3% during the second quarter. Captrust Financial Advisors now owns 33,273 shares of the company’s stock worth $997,000 after buying an additional 4,163 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.